BRIEF-China Resources Pharmaceutical Posts FY Results For CR Double-Crane Pharmaceutical

Reuters
19 Mar
BRIEF-China Resources Pharmaceutical Posts FY Results For CR Double-Crane Pharmaceutical

March 19 (Reuters) - China Resources Pharmaceutical Group Ltd 3320.HK:

  • FY NET PROFIT ATTRIBUTABLE FOR CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL RMB1.63 BILLION

  • FY REVENUE RMB11.21 BILLION FOR CR DOUBLE-CRANE

  • CR DOUBLE-CRANE PROPOSED CASH DIVIDEND OF RMB3.71 FOR EVERY 10 SHARES

Further company coverage: 3320.HK

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10